Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMI-137 Fluorescence Endoscopy in Barrett's Esophagus
NCT03205501Phase 1Completed
- Sponsor
- University Medical Center Groningen
- Start
- Feb 2017
- Primary completion
- Mar 2019
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of emi-137 in Barrett's esophagus and esophageal cancer, sponsored by University Medical Center Groningen. Primary endpoints: Tumor-to-background ratio at Day 1 and Safety. Started Feb 2017; status: completed.
02
Drugs
emi-137
03
Conditions
Barrett's esophagusesophageal cancer
Beyond the preview
Go deeper on NCT03205501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03205501.